PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Current Liabilities | ₹4,457 Cr | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹4,457 Cr |
Mar2023 | ₹3,851 Cr |
Mar2022 | ₹3,118 Cr |
Mar2021 | ₹2,591 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,457 Cr | 15.74 | |
Mar2023 | ₹3,851 Cr | 23.51 | |
Mar2022 | ₹3,118 Cr | 20.35 | |
Mar2021 | ₹2,591 Cr | - |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹27,394.8 Cr | 0.1% | -2.8% | 43.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.1% |
-2.8% |
43.9% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses